We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




CSF Cytokine Characteristics Defined from Children with Meningitis

By LabMedica International staff writers
Posted on 21 Jan 2020
Print article
Image: The BD Bactec FX40: the blood culturing instruments used with patented resin-containing media have shown higher rates of organism recovery, allowing for proper diagnosis and treatment of bloodstream infections (Photo courtesy of Becton, Dickinson and Company).
Image: The BD Bactec FX40: the blood culturing instruments used with patented resin-containing media have shown higher rates of organism recovery, allowing for proper diagnosis and treatment of bloodstream infections (Photo courtesy of Becton, Dickinson and Company).
Enteroviral meningitis (EVM) are the most common etiological agent for viral encephalitis, and are predominantly reported among children and always present as a milder clinical illness than other infectious causes which only need supportive therapy.

However, bacterial meningitis (BM) is still associated with a high morbidity and mortality rate. Appropriate antibiotics treatment is essential to optimize outcomes. Cytokines are regarded as having important roles in meningeal inflammation in patients with central nervous system (CNS) infection.

Clinical scientists at the Zhejiang University School of Medicine (Hangzhou, China) carried a retrospective study and collected cerebrospinal fluid CSF and/or blood specimens for microbiological culture, viruses, and cytokine detection. Patients were categorized into three groups: EVM group: Patients with EVM were confirmed by the presence of pleocytosis and detection of enteroviral nucleic acid detection in CSF using polymerase chain reaction (PCR); BM group: Patients with bacterial meningitis who were diagnosed as having significant CSF white blood cell counts; Control group: children with febrile seizures who underwent lumbar puncture and had normal CSF.

CSF specimens and blood samples were taken for microbiological culture. Samples were injected into children's blood culture bottles (BACTEC FX400, Becton, Dickinson and Company, Franklin Lakes, NJ, USA) for enrichment culture. MALDI‐TOF (BRUKER, Billerica, MA, USA) was used for bacterial identification and VITEK 2 compact (bioMérieux, Marcy-l'Étoile, France) for bacterial drug sensitivity. Serum and CSF concentration of cytokines interleukin (IL)‐2, IL‐6, IL‐10, tumor necrosis factor (TNF), and interferon (IFN)‐γ were quantitatively determined by the CBA kit–BD CBA Human Th1/Th2 Cytokine Kit II (BD Biosciences, San Jose, CA, USA). The detection of EVs was performed by using commercial one‐step real‐time RT‐PCR assay kit.

The scientists reported that 43 patients were confirmed with meningitis, 27 patients with EVM, and 16 with BM. Children with EVM were older compared with BM and control group. Serum IL‐6 and serum IL‐10 were lower in EVM group than BM and control group. IL‐6, IL‐10, and IFN‐γ levels showed obviously increase in CSF in EVM group, while only IL‐6 increased in CSF in BM group. CSF concentrations of cytokines IL‐6, IL‐10, TNF, and IFN‐γ in children with EVM and BM were both higher than control group, but compared EVM group to BM group, CSF IL‐2, TNF, and IFN‐γ showed no difference between two groups.

The authors concluded that CSF cytokines elevated in both virus and bacterial meningitis, while serum elevation only occurred in bacterial infection. However, they could not distinguish enteroviral meningitis from bacterial meningitis with the parameters of CSF cytokines IL‐2, IL‐6, IL‐10, TNF, and IFN‐γ. The study was published on January 8, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Zhejiang University School of Medicine
Becton, Dickinson and Company
BRUKER
bioMérieux
BD Biosciences


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Creatine Kinase-MB Assay
CK-MB Test
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.